FLUID PHARMA LTD - HARROGATE
Company Profile | Company Filings |
Overview
FLUID PHARMA LTD is a Private Limited Company from HARROGATE ENGLAND and has the status: Active.
FLUID PHARMA LTD was incorporated 8 years ago on 03/03/2016 and has the registered number: 10040765. The accounts status is MICRO ENTITY and accounts are next due on 31/12/2024.
FLUID PHARMA LTD was incorporated 8 years ago on 03/03/2016 and has the registered number: 10040765. The accounts status is MICRO ENTITY and accounts are next due on 31/12/2024.
FLUID PHARMA LTD - HARROGATE
This company is listed in the following categories:
72110 - Research and experimental development on biotechnology
72110 - Research and experimental development on biotechnology
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 3 | 31/03/2023 | 31/12/2024 |
Registered Office
WINDSOR HOUSE
HARROGATE
HG1 2PW
ENGLAND
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
03/07/2023 | 17/07/2024 |
Map
ENGLAND
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
IP2IPO SERVICES LIMITED | Corporate Director | 2016-03-03 | CURRENT | ||
HADDLETON & CO LIMITED | Corporate Secretary | 2020-08-05 | CURRENT | ||
DR FANG LIU | Jan 1973 | British | Director | 2016-03-03 | CURRENT |
DR DARRAGH MURNANE | Jul 1978 | Irish | Director | 2016-03-03 | CURRENT |
IP2IPO SERVICES LIMITED | Corporate Secretary | 2016-03-03 UNTIL 2020-07-13 | RESIGNED |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Ip2ipo Portfolio (Gp) Limited | 2017-06-13 | London | Ownership of shares 50 to 75 percent | |
Ip2ipo Limited | 2016-05-19 - 2017-06-13 | London | Ownership of shares 50 to 75 percent |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
Micro-entity Accounts - FLUID PHARMA LTD | 2021-01-12 | 31-03-2020 | £173,053 equity |